(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities

(2/2) CDU/UCLA 癌症中心合作消除癌症健康差异

• 批准号: 10247107
• 负责人: Richard Joseph Pietras
• 金额: $ 34.5万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-29 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10247107
• 关键词: Address; Area; Award; California; Cancer Burden; Cancer Center; Cancer Research Infrastructure; Cancer Research Project; Catchment Area; Clinical; Clinical Research; Clinical Trials; Collaborations; Communities; Community Outreach; Comprehensive Cancer Center; Counseling; County; Databases; Development; Education; Education and Outreach; Evaluation; Faculty; Focus Groups; Funding; Goals; Grant; Health; Hispanic-serving Institution; Historically Black Colleges and Universities; Incidence; Infrastructure; Institution; Investments; Linguistics; Los Angeles; Malignant Neoplasms; Medical Students; Medicine; Mentors; Mentorship; Minority; Minority-Serving Institution; Mississippi; NCI-Designated Cancer Center; National Cancer Institute; Outcome; Pilot Projects; Population; Postdoctoral Fellow; Prevention strategy; Program Development; Research; Research Personnel; Research Project Grants; Resource Sharing; Resources; Rivers; Science; Scientist; Students; Training; Training and Infrastructure; Underrepresented Minority; Underrepresented Populations; Underserved Population; Universities; anticancer research; biobank; cancer education; cancer health disparity; career; career development; clinical biomarkers; data resource; demographics; education research; health disparity; health equity; institutional capacity; minority investigator; minority student; outreach; programs; public health relevance; recruit; research facility; socioeconomic disadvantage; success; tissue biomarkers; tissue resource; undergraduate student

DESCRIPTION (provided by applicant) : The Charles R. Drew University (CDU) and the UCLA Jonsson Comprehensive Cancer Center has forged a strong and sustainable partnership to "Eliminate Cancer Health Disparities in minority and underserved populations". Our partnership began in 2003 with support from the National Cancer Institute to initiate U56 collaboration, followed by a U54 award in 2009 to establish a long lasting comprehensive partnership. In addition, institutional investment from UCLA-JCCC and CDU has made it possible for a sustainable partnership to accomplish significant goals related to reducing cancer health disparities. Hence, in our renewal application, we propose to continue the momentum and do more to address cancer health disparities in our communities in Los Angeles County, and in particular South Los Angeles. The overarching goals of the CDU-UCLA Cancer Partnership Program are to significantly increase the number of scientists in cancer research and to enhance the cancer research and infrastructure capacity at Charles Drew University of Medicine and Science that will continue to address significant disparities in cancer among minority populations. Supported and implemented by an Administrative Core, Planning and Evaluation Core, and Research Projects, Research Education Core, Outreach Core, and Shared Resources Core. The five priorities for the partnership are: Priority 1: Increase the number and quality of cancer research projects at CDU by supporting full and pilot projects and increase the number of cancer researchers at CDU. Priority 2: Enhance research capability of the CDU's Integrated Clinical and Biomarker/ Biorepository Tissue and Data Resources focused on cancer health disparities research, education and outreach among underrepresented populations. Priority 3: Create institutional capacity at CDU for performing cancer-related clinica trials by leveraging the community and existing clinical research facilities and resources. Priorit 4: Expose undergraduate and medical students, fellows, and faculty to cancer research and encourage them to pursue or advance their careers in this area, and implement a formalized mentorship program whereby junior research investigators are counseled and mentored during their career development. Priority 5: Bring culturally and linguistically appropriate cancer research information to the community and increase community capacity to develop and implement culturally appropriate health prevention strategies through community-partnered participatory research.

描述（由应用程序提供）：查尔斯·R·德鲁大学（CDU）和加州大学洛杉矶分校乔恩森综合癌症中心忘记了强大而可持续的伙伴关系，以“消除少数群体和服务不足人群的癌症健康差异”。我们的合作伙伴关系始于2003年，始于国家癌症研究所（National Cancer Institute）启动U56合作，然后于2009年获得U54奖，以建立持久的综合合作伙伴关系。此外，UCLA-JCCC和CDU的机构投资使可持续合作伙伴关系可以实现与减少癌症健康分布有关的重要目标。因此，在我们的续签申请中，我们建议继续势头，并做更多的事情，以解决我们洛杉矶县社区，尤其是南洛杉矶社区的癌症健康分布。 CDU-UCLA癌症伙伴关系计划的总体目标是显着增加癌症研究中的科学家的数量，并增强查尔斯·德鲁医学与科学大学的癌症研究和基础设施能力，该大学将继续解决少数人群中癌症中的重大分布。由行政核心，计划和评估核心以及研究项目，研究教育核心，外展核心和共享资源核心的支持和实施。合作伙伴关系的五个优先事项是：优先级1：通过支持完整和试点项目并增加CDU的癌症研究人员的数量来增加CDU的癌症研究项目的数量和质量。优先级2：增强CDU综合临床和生物标志物/生物措施组织和数据资源的研究能力，这些组织和数据资源着重于癌症健康分布研究，教育和代表性不足的人群中。优先级3：通过利用社区以及现有的临床研究设施和资源来创建CDU的机构能力，以进行与癌症相关的临床试验。优先4：揭露本科生和医学生，研究员和教职员工进行癌症研究，并鼓励他们从事或促进该领域的职业，并实施正式的心态计划，在该计划中，初级研究调查人员在职业发展过程中得到了培养和修补。优先级5：通过文化和语言上适当的癌症研究信息将其带到社区，并通过社区合作的参与研究来提高社区发展和实施适当的健康预防健康预防策略。

项目成果

Genomic Analysis of Invasive Human Bone Marrow Derived Mesenchymal Stem Cells.

• DOI: 10.4172/2329-8820.1000122
• 发表时间: 2013-05-23
• 期刊: Journal of bone marrow research
• 作者: Mathews LA;Hurt EM;Zhang X;Farrar WL
• 通讯作者: Farrar WL

Endometriosis: A Malignant Fingerprint.

• DOI: 10.17303/jcrto.2020.8.206
• 发表时间: 2020-04-01
• 期刊: Journal of cancer research and therapeutic oncology
• 作者: DeAngelo, Christopher;Tarasiewicz, Megan Burnett;Farias-Eisner, Robin
• 通讯作者: Farias-Eisner, Robin

Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features.

• DOI: 10.3892/ijo.2016.3800
• 发表时间: 2017-01
• 期刊: International journal of oncology
• 影响因子: 5.2
• 作者: Gelfand R;Vernet D;Bruhn KW;Sarkissyan S;Heber D;Vadgama JV;Gonzalez-Cadavid NF
• 通讯作者: Gonzalez-Cadavid NF

Evidence for the Full Potential of Daily Food Choices to Minimize Premature Mortality.

• DOI: 10.1001/jamainternmed.2019.2205
• 发表时间: 2019-08
• 期刊: JAMA internal medicine
• 影响因子: 39
• 作者: W. McCarthy;Folasade P. May